Top 50 Funds, GSK & Mondi: The Companies and Markets Show
We start with last week’s Big Read, our annual Top 50 Funds. Dave Baxter shares his thoughts on compiling the list, its structure and the changes made to this year's edition. GSK (GSK), a company featured in our latest Special Report this week, Income Majors, is next. Its dividend level is not as high as it has been,…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Investors' Chronicle
See all episodes →
Similar episodes from other shows
More like Investors' Chronicle →
Greenwashing, Rolls Royce, small caps and NS&I rate cuts
Is the FTSE 100 finally having its moment in the sun?
Markets Round Up: Private Equity, ISAs, Rachel Reeves
Anna Macdonald: hunting down the big companies of tomorrow
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.